Literature DB >> 3524879

Imported cases of chloroquine-resistant falciparum malaria in Iran.

G H Edrissian, S Shahabi, E Pishva, J Hajseyed-Javadi, B Khaleghian, M Ghorbani, A M Emadi, A Afshar, H Saghari.   

Abstract

Six imported cases of chloroquine-resistant Falciparum malaria have been studied since October 1984. In five cases including two Iranian men, returned from India, two Afghan and one Bengalee immigrants came to Iran through Pakistan, recrudescence occurred following treatment with chloroquine. In these five cases resistance of P. falciparum to chloroquine was clinically (by the in vivo test) at R1 level in all patients. The resistance was also confirmed by the macro in vitro susceptibility test which was carried out in four of them. These five chloroquine-resistant cases were treated, one with Sulfadiazine-Pyrimethamine, three with Quinine-Sulfadiazine-Pyrimethamine and one with Sulfadoxine-Pyrimethamine (Fansidar) successfully. In the sixth case who was a Pakistani tourist the parasites showed resistance in the macro in vitro test, but apparently responded to chloroquine treatment in three days. It seems the resistance in this case was also at R1 level as other cases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524879

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  4 in total

1.  Genetic polymorphism at the C-terminal domain (region III) of knob-associated histidine-rich protein (KAHRP) of Plasmodium falciparum in isolates from Iran.

Authors:  Ahmad Mardani; Hossein Keshavarz; Aliehsan Heidari; Homa Hajjaran; Ahmad Raeisi; Mohammad Reza Khorramizadeh
Journal:  Parasitol Res       Date:  2011-05-20       Impact factor: 2.289

2.  In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense.

Authors:  Ali Ramazani; Sedigheh Zakeri; Soroush Sardari; Nastaran Khodakarim; Navid Dinparas Djadidt
Journal:  Malar J       Date:  2010-05-12       Impact factor: 2.979

3.  Evaluation of the Antimalarial Effect of Ferulago angulata (Schlecht.) Boiss. Extract and Suberosin Epoxide Against Plasmodium berghei in Comparison with Chloroquine Using in-vivo Test.

Authors:  Seyed Ebrahim Sajjadi; Nader Pestechian; Mahnaz Kazemi; Mohammad-Ali Mohaghegh; Ahmad Hosseini-Safa
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

4.  Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.

Authors:  Sedigheh Zakeri; Mandana Afsharpad; Ahmad Raeisi; Navid Dinparast Djadid
Journal:  Malar J       Date:  2007-11-13       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.